Clinical Trial Update: A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of capecitabine (Xeloda) in advanced or metastatic colorectal cancer, sponsored by Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED